Navigation Links
HIVMA opposes The Gambia's unproven AIDS remedy

Leading HIV experts are alarmed that the government of The Gambia is encouraging citizens living with HIV to stop taking antiretroviral medications in order to try an unproven herbal remedy. The HIV Medicine Association (HIVMA) calls on President Yahya Jammeh to cease his unproven claims that the treatment "cures" AIDS.

Earlier this year, President Jammeh began applying his treatment to a handful of patients who had been doing well on antiretroviral therapy but stopped taking the drugs in order to qualify to receive his "cure."

HIVMA joins its colleagues in the International AIDS Society and the Society for AIDS in Africa in expressing great concern regarding this practice. "There currently is no cure for HIV/AIDS," said HIVMA Chair Daniel R. Kuritzkes, MD. "President Jammeh is giving people false hope, while at the same time making them stop treatment that has been demonstrated to save lives."

"Any treatment that claims to alleviate this devastating disease must be subjected to rigorous scientific scrutiny," he added. "A growing body of evidence from Africa shows the lifesaving effects of antiretroviral medicines for people living with HIV/AIDS. On the other hand, the remedy President Jammeh is promoting is untested. It is highly unethical to stop a proven therapy to try an unproven one. We are extremely concerned that President Jammeh would recklessly experiment with his people’s lives."

"We support the tireless efforts of African scientists, clinicians, and community health workers providing antiretroviral treatment to communities that are so deeply affected by this disease." Dr. Kuritzkes added. "We urge the government of the Gambia to support their efforts as well."

Dr. Kuritzkes concluded, "People around the world living with HIV/AIDS deserve safe, effective, and affordable treatment, regardless of the source. If President Jammeh’s remedy is as effective as he claims, it will stand up to examination. In the mean time, we urge patients receiving his unproven herbal remedy to resume taking their antiretroviral medications, which have a well-established track record of saving lives in Africa."

Source:Infectious Diseases Society of America

Related biology news :

1. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy
2. Medical whistleblowers speak out
3. The evolutionary triumph of flower power
4. Bumblebees copy one another when contending with unfamiliar flowers
5. Analysis of flower genes reveals the fate of an ancient gene duplication
6. Gene therapy to lower blood pressure just enough
7. Long-sought flower-inducing molecule found
8. Divergent mating systems and parental conflict as a barrier to hybridization in flowering plants
9. Reducing antibiotic use lowers rates of drug-resistant bacteria
10. Recreating Flowers for Algernon with a happy ending
11. Overfishing may drive endangered seabird to rely upon lower quality food

Post Your Comments:

(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: ... for financial services, but it also plays a fundamental part ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology: